- Low bankruptcy risk (Altman Z-Score: 5.92)
- Highly efficient cash conversion (101% FCF/OCF ratio)
- High gross margin of 54.1%
Janux Therapeutics, Inc. stock price down 1.38% on Wednesday
(Updated on Jun 03, 2026)
The Janux Therapeutics, Inc. stock price fell by -1.38% on the last day (Wednesday, 3rd Jun 2026) from $13.78 to $13.59. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 2.38% from a day low at $13.45 to a day high of $13.77. The price has been going up and down for this period, and there has been a -1.59% loss for the last 2 weeks. Volume has increased on the last day by 4 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 684 thousand shares were bought and sold for approximately $9.29 million.
The stock lies in the lower part of a wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $13.35 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 2.84% during the next 3 months and, with a 90% probability hold a price between $13.73 and $16.55 at the end of this 3-month period.
JANX Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Janux Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $14.28 and $14.58. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 28, 2026, and so far it has fallen -7.80%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Janux Therapeutics, Inc. stock
Janux Therapeutics, Inc. finds support from accumulated volume at $13.58 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.320 between high and low, or 2.38%. For the last week the stock has had daily average volatility of 3.19%.
Our recommended stop-loss: $12.87 (-5.30%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 4 days ago.)
Trading Expectations (JANX) For The Upcoming Trading Day Of Thursday 4th
For the upcoming trading day on Thursday, 4th we expect Janux Therapeutics, Inc. to open at $13.60, and during the day (based on 14 day Average True Range), to move between $13.33 and $13.85, which gives a possible trading interval of +/-$0.515 (+/-3.86%) up or down from last closing price. If Janux Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 3.86% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $13.58 (0.07%) than the resistance at $13.81 (1.62%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Janux Therapeutics, Inc. stock A Buy?
Janux Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
0.331
Hold/Accumulate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 4, 2026 - $13.60 ( 0.0981%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
JANX Performance
Trading levels for JANX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 13.92 | 2.45% |
| R2 | 13.80 | 1.55% |
| R1 | 13.73 | 1.00% |
| Price | 13.59 | |
| S1 | 13.48 | -0.80% |
| S2 | 13.41 | -1.36% |
| S3 | 13.28 | -2.26% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 15.87 | 16.78% |
| R2 | 14.06 | 3.46% |
| R1 | 13.81 | 1.62% |
| Price | 13.59 | |
| S1 | 13.58 | -0.0736% |
| S2 | 13.56 | -0.221% |
| S3 | 13.18 | -3.02% |
FAQ
Click here for our free guide on how to buy Janux Therapeutics, Inc. Stock.
Buy JANX